$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Mechanisms of Myotonic Dystrophies 1 and 2 원문보기

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, v.9 no.1, 2005년, pp.1 - 8  

Lubov, Timchenko (Department of Medicine, Section of Cardiovascular Sciences, Baylor College of Medicine)

Abstract AI-Helper 아이콘AI-Helper

Myotonic Dystrophies type 1 and 2 (DM1/2) are neuromuscular disorders which belong to a group of genetic diseases caused by unstable CTG triplet repeat (DM1) and CCTG tetranucleotide repeat (DM2) expansions. In DM1, CTG repeats are located within the 3' untranslated region of myotonin protein kinase...

주제어

참고문헌 (45)

  1. Amack JD, Mahadevan MS. The myotonic dystrophy expanded CUG repeat track is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum Mol Genet 10: 1879-1887, 2001 

  2. Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, Clen C, Alleman J, Wormskamp NG, Vooijs M, Buxton J, Johnson K, Sweets HJM, Lennon GG, Carrano AV, Korneluk RG, Wieringa B, deJong PJ. Cloning of essential myotonic dystrophy region and mapping of the putative defect. Nature 355: 548-551, 1992 

  3. Baldwin BR, Timchenko NA, Zahnow CA. Epidermal growth factor receptor stimulation activates the RNA binding protein CUGBP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol Cell Biol 24: 3682-3691, 2004 

  4. Brook JD, McCurrah ME, Harley HG, Buckler AJ, Church D, Aburatan H, Hunter K, Stanton VP, Thirion J-P, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of atrinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68: 799-808, 1992 

  5. Calkhoven CF, Bouwman PRJ, Snippe L, Geert AB. Translation start site multiplicity of the CCAAT/enhancer binding protein $\alpha$ mRNA is dictated by a small 5' open reading frame. Nucl Acids Res 22: 5540-5547, 1994 

  6. Calkhoven CF, Muller C, Leutz A. Translational control of C/EBP $\alpha$ and C/EBP $\beta$ isoform expression. Genes & Dev 14: 1920-1932, 2000 

  7. Charlet-B N, Savcur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the Muscle specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45-43, 2002 

  8. Cooper TA, Ordahl CP. A single troponin T gene regulated by different programs in cardiac and skeletal muscle development. Science 226: 979-982, 1984 

  9. Cooper TA, Ordahl CP. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J Biol Chem 260: 11140-11148, 1985 

  10. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LPW. Myotonic dystrophy type 2. Neurol 60: 657- 664, 2003 

  11. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579, 1991 

  12. Ebralidze A, Wang Y, Petkova V, Ebralidze K, Junghans RP. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303: 383-387, 2004 

  13. Fardaei M, Larkin K, Brook JD, Hamshere MG. In vivo co localization of MNBL protein with DMPK expanded- repeat transcripts. Nucl Acids Res 29: 2766-2771, 2001 

  14. Finsterer J. Myotonic Dystrophy type 2. Eur J Neurol 9: 441-447, 2002 

  15. Fu YH, Friedman DL, Richards S, Pearlman JA, Gibbs RA, Pizzuti A, Ashizawa T, Perryman MB, Scarlato G, Fenwick RG, Caskey CT. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260: 235-238, 1993 

  16. Fu YH, Pizzuti RG, Fenwick JK Jr, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, DeJong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258, 1992 

  17. Harper PS. Myotonic Dystrophy. WB Saunders, London, UK, 2001 

  18. Iakova P, Wang G-L, Timchenko, L, Michalak M, Pereira-Smith OM, Smith JR, Timchenko NA. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determined cell fate. EMBO J 23: 407-417, 2004 

  19. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thrornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for Myotonic dystrophy. Science 302: 1978-1980, 2003 

  20. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LPW. Myotonic dystrophy type 2 caused by a CCTG expansion in intron of ZNF9. Science 293: 864-867, 2001 

  21. Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, Manns MP, Trautwein C. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 40: 356-365, 2004 

  22. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-MacDonald J, De Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255: 1253-1256, 1992 

  23. Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10: 2165-2170, 2001 

  24. Mankodi M, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289: 1769-1772, 2000 

  25. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J 19: 4439-4448, 2000 

  26. Molkentin JD, Black BL, Martin JF, Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic transcription factors. Cell 83: 1125-11330, 1995 

  27. Otten AD, Tapscott SJ. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci (USA) 92: 5465-5469, 1995 

  28. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing of regulated by CUG binding protein in myotonic dystrophy. Science 280: 737-741, 1998 

  29. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273: 29279-29282, 1998 

  30. Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 74: 793-804, 2004 

  31. Savcur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LPW, Day JW. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74: 1309-1313, 2004 

  32. Savcur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29: 40-47, 2001 

  33. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros Brisson E, Fouquet C, Butler-Browne G, Delacourte A, Junien C, Gourdon G. Mice transgenic for the human myotonic dystrophy with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 10: 2717-2726, 2001 

  34. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128: 995-1002, 1995 

  35. Timchenko LT. Myotonic dystrophy: the role of RNA CUG repeats. Am J Hum Genet 64: 360-364, 1999 

  36. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Identification of a (CUG) ntriplet repeat binding protein and its expression in myotonic dystrophy. Nucl Acids Res 24: 4407-44116, 1996 

  37. Timchenko LT, Timchenko NA, Caskey CT, Roberts R. Novel proteins with binding specificity to DNA CTG and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 5: 115-121, 1996 

  38. Timchenko NA, Cai Z-J, Welm AL, Reddy S, Ashizawa T, Timchenko LT. RNA CUG repeats sequester and alter protein levels and activity of CUGBP1. J Biol Chem 276: 7820-7826, 2001 

  39. Timchenko NA, Iakova P, Cai Z-J, Smith JR, Timchenko LT. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 21: 6927-6938, 2001 

  40. Timchenko NA, Patel R, Iakova P, Cai Z-J, Quan L, Timchenko LT. Overexpression of CUG triplet repeat- binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 279: 13129-13139, 2004 

  41. Timchenko NA, Welm AL, Lu X, Timchenko LT. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/ EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucl Acids Res 27: 4517-4525, 1999 

  42. Udd B, Krahe R, Wallgren-Petterson C, Falck B, Kalimo H. Proximal myotonic dystrophy - a family of with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism:heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 7: 217-228, 1997 

  43. Welm AL, Mackey SL, Timchenko LT, Darlington GJ, Timchenko NA. Translational Induction of Liver-enriched Transcriptional Inhibitory Protein during Acute Phase Response Leads to Repression of CCAAT/Enhancer Binding Protein $\alpha$ mRNA. J Biol Chem 275: 27406-27413, 2000 

  44. Wu H, Olson EN. Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice. J Clin Invest 109: 1327-1333, 2002 

  45. Zhang P, Wong C, Liu D, Finegold M, Harper WJ, Elledge SJ. P21 (CIP1) and p57 (KIP2) control muscle differentiation at the myogenin step. Genes Dev 13: 213-224, 1999 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로